Leukemia M4 is acute granulomonocytic leukemia, and its survival time varies from person to person, depending on the patient’s condition, disease progression, age, and treatment, and cannot be generalized. 1. If the patient does not receive active and effective treatment, the survival time is usually short, usually around six months. 2. If effective treatment is received, such as chemotherapy (cytarabine) and bone marrow transplantation, the survival time will be greatly prolonged, and some patients can even reach clinical cure. The 5-year survival rate of acute granulomonocytic leukemia is not high, usually around 30%, so if you are diagnosed with this disease, you must go to the hospital in time to receive regular treatment. The earlier it is detected and treated, the higher the survival rate of patients.